Abiomed (ABMD) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Abiomed (ABMD) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: June 3, 2023 (10:35)

Sector: Healthcare

The share price of Abiomed, Inc. (ABMD) now

What analysts predict: $
52-week High/Low: $ / $

50/200 Day Moving Average: $ / $

This figure corresponds to the Average Price over the previous 50/200 days. For Abiomed stocks, the 50-day moving average is the support level today.

For Abiomed stocks, the 200-day moving average is the support level today.

Are you interested in Abiomed, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Abiomed stock price in 2023, 2024, 2025, 2026, 2027. How much will one Abiomed share be worth in 2023 - 2027?

When should I take profit in Abiomed stock? When should I record a loss on Abiomed stock? What are analysts' forecasts for Abiomed stock? What is the future of Abiomed stock? We forecast Abiomed stock performance using neural networks based on historical data on Abiomed stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Abiomed stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Abiomed shares. This happens once a day.


Sell or Buy Abiomed (ABMD) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the ABMD stock market. Experts share their opinions on what to expect from the … Read more



Historical and forecast chart of Abiomed stock

The chart below shows the historical price of Abiomed stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Abiomed stock price can be found in the table below.

Long-term forecasts by years.

Abiomed daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 05 395.25 389.22 398.31 2.34
Jun 06 390.70 385.52 396.07 2.74
Jun 07 385.23 381.28 389.66 2.20
Jun 08 389.76 383.23 397.55 3.74
Jun 09 385.76 382.48 389.14 1.74
Jun 10 383.16 377.79 388.14 2.74
Jun 11 383.92 379.32 386.52 1.90
Jun 12 384.21 377.20 387.96 2.85
Jun 13 379.79 375.52 386.72 2.98
Jun 14 381.88 376.15 385.61 2.51
Jun 15 373.29 368.25 375.16 1.88
Jun 16 379.26 376.61 386.18 2.54
Jun 17 374.52 370.96 378.36 1.99
Jun 18 370.12 365.31 372.90 2.08
Jun 19 371.88 368.72 377.09 2.27
Jun 20 381.18 377.56 386.32 2.32
Jun 21 382.42 379.45 389.20 2.57
Jun 22 381.17 373.55 387.46 3.72
Jun 23 382.89 375.61 385.95 2.75
Jun 24 378.20 375.27 383.87 2.29
Jun 25 376.40 369.44 381.20 3.18
Jun 26 376.68 373.01 379.23 1.67
Jun 27 372.26 365.09 377.84 3.49
Jun 28 373.56 370.94 380.00 2.44
Jun 29 370.94 367.98 377.62 2.62
Jun 30 379.29 375.88 381.95 1.61
Jul 01 379.20 374.74 385.64 2.91
Jul 02 382.32 378.12 387.68 2.53
Jul 03 382.42 376.78 388.73 3.17
Jul 04 383.85 381.84 389.71 2.06

Abiomed Daily Price Targets


Abiomed Stock Forecast 06-05-2023.

Forecast target price for 06-05-2023: $395.25.
Positive dynamics for Abiomed shares will prevail with possible volatility of 2.282%.
Pessimistic target level: 389.22
Optimistic target level: 398.31

Abiomed Stock Forecast 06-06-2023.

Forecast target price for 06-06-2023: $390.70.
Negative dynamics for Abiomed shares will prevail with possible volatility of 2.663%.
Pessimistic target level: 385.52
Optimistic target level: 396.07

Abiomed Stock Forecast 06-07-2023.

Forecast target price for 06-07-2023: $385.23.
Negative dynamics for Abiomed shares will prevail with possible volatility of 2.150%.
Pessimistic target level: 381.28
Optimistic target level: 389.66

Abiomed Stock Forecast 06-08-2023.

Forecast target price for 06-08-2023: $389.76.
Positive dynamics for Abiomed shares will prevail with possible volatility of 3.603%.
Pessimistic target level: 383.23
Optimistic target level: 397.55

Abiomed Stock Forecast 06-09-2023.

Forecast target price for 06-09-2023: $385.76.
Negative dynamics for Abiomed shares will prevail with possible volatility of 1.710%.
Pessimistic target level: 382.48
Optimistic target level: 389.14

Abiomed Stock Forecast 06-10-2023.

Forecast target price for 06-10-2023: $383.16.
Negative dynamics for Abiomed shares will prevail with possible volatility of 2.665%.
Pessimistic target level: 377.79
Optimistic target level: 388.14

ABMD (ABMD) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jul. 410.49 396.54 418.17 5.17
Aug. 441.20 429.95 467.07 7.95
Sep. 436.32 414.81 443.74 6.52
Oct. 447.08 420.48 466.46 9.86
Nov. 424.66 403.00 453.53 11.14
Dec. 432.96 418.61 446.21 6.19

Abiomed forecast for this year


Abiomed Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $410.492. Pessimistic: $396.54. Optimistic: $418.17


Abiomed Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $441.197. Pessimistic: $429.95. Optimistic: $467.07


Abiomed Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $436.321. Pessimistic: $414.81. Optimistic: $443.74


Abiomed Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $447.077. Pessimistic: $420.48. Optimistic: $466.46


Abiomed Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $424.656. Pessimistic: $403.00. Optimistic: $453.53


Abiomed Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $432.958. Pessimistic: $418.61. Optimistic: $446.21



Abiomed (ABMD) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 459.46 448.52 489.53 8.38
Feb 446.18 422.28 457.18 7.63
Mar 438.97 425.54 455.76 6.63
Apr 425.91 408.17 439.31 7.09
May 418.31 410.13 437.51 6.26
Jun 432.89 420.75 446.13 5.69
Jul 450.18 441.38 463.96 4.87
Aug 437.94 429.37 463.62 7.39
Sep 464.74 454.86 474.22 4.08
Oct 500.69 487.49 518.56 5.99
Nov 481.96 453.28 500.80 9.49
Dec 504.49 494.20 531.08 6.94

Abiomed (ABMD) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 494.20 467.74 526.13 11.10
Feb 466.90 448.64 479.20 6.38
Mar 481.98 456.58 513.52 11.09
Apr 485.25 467.11 512.48 8.85
May 472.05 441.16 500.54 11.86
Jun 477.27 453.74 486.20 6.68
Jul 471.59 457.56 484.82 5.62
Aug 500.45 475.36 530.66 10.42
Sep 512.79 499.71 543.74 8.10
Oct 504.94 482.62 531.98 9.28
Nov 504.51 493.36 521.24 5.35
Dec 522.53 501.21 545.62 8.14

Abiomed (ABMD) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 522.53 509.65 557.61 8.60
Feb 544.73 527.60 576.68 8.51
Mar 541.03 506.54 562.18 9.90
Apr 544.71 512.76 553.97 7.44
May 522.02 505.60 535.33 5.55
Jun 520.69 507.85 532.64 4.65
Jul 533.97 521.71 562.11 7.19
Aug 517.17 498.27 534.76 6.82
Sep 550.58 535.14 566.03 5.46
Oct 515.95 497.97 541.83 8.09
Nov 503.67 470.71 515.66 8.72
Dec 487.40 470.83 510.19 7.71

Abiomed (ABMD) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 472.07 454.42 489.33 7.13
Feb 487.32 468.27 520.05 9.96
Mar 482.77 468.40 512.31 8.57
Apr 511.49 478.88 540.62 11.42
May 552.79 519.43 579.58 10.38
Jun 563.60 529.11 600.97 11.96
Jul 562.64 543.99 578.42 5.95
Aug 566.95 530.80 599.23 11.42
Sep 578.51 545.07 609.98 10.64
Oct 575.56 562.35 593.17 5.20
Nov 555.50 529.06 567.31 6.74
Dec 570.61 537.63 588.56 8.65

Abiomed information and performance

Abiomed is a manufacturer of medical implants, including the AbioCor artificial heart and impella. The company is headquartered in Danvers, Massachusetts and has three subsidiary offices: two in Germany in Berlin and Aachen and one in Japan. Michael R. Minogue joined Abiomed in 2004 and serves as CEO, Chairman and President.

Abiomed Address

N/A

Market Capitalization: N/A $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: N/A $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: N/A

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: N/A

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: N/A

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: N/A

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: N/A

Enterprise Value (EV) /Revenue

EV To EBITDA: N/A

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: N/A

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.